Title : Effects of taurochenodeoxycholic acid on adjuvant arthritis in rats.

Pub. Date : 2011 Dec

PMID : 21983642






12 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The overproduction and mRNA expression of TNF-alpha, IL-1beta and IL-6 were remarkably suppressed in serum and synovium tissue of all TCDCA-treated rats, however, IL-10 was markedly increased in prophylactic treatment. Taurochenodeoxycholic Acid tumor necrosis factor Rattus norvegicus
2 The overproduction and mRNA expression of TNF-alpha, IL-1beta and IL-6 were remarkably suppressed in serum and synovium tissue of all TCDCA-treated rats, however, IL-10 was markedly increased in prophylactic treatment. Taurochenodeoxycholic Acid interleukin 1 beta Rattus norvegicus
3 The overproduction and mRNA expression of TNF-alpha, IL-1beta and IL-6 were remarkably suppressed in serum and synovium tissue of all TCDCA-treated rats, however, IL-10 was markedly increased in prophylactic treatment. Taurochenodeoxycholic Acid interleukin 6 Rattus norvegicus
4 The overproduction and mRNA expression of TNF-alpha, IL-1beta and IL-6 were remarkably suppressed in serum and synovium tissue of all TCDCA-treated rats, however, IL-10 was markedly increased in prophylactic treatment. Taurochenodeoxycholic Acid interleukin 10 Rattus norvegicus
5 In a definite concentration ranging from 300 mug/mL to 500 mug/mL, TCDCA showed marked inhibition in the overproduction and mRNA expression of TNF-alpha, IL-1beta and IL-6 in synoviocytes in a concentration-dependent manner, but opposite action on IL-10. Taurochenodeoxycholic Acid tumor necrosis factor Rattus norvegicus
6 In a definite concentration ranging from 300 mug/mL to 500 mug/mL, TCDCA showed marked inhibition in the overproduction and mRNA expression of TNF-alpha, IL-1beta and IL-6 in synoviocytes in a concentration-dependent manner, but opposite action on IL-10. Taurochenodeoxycholic Acid interleukin 1 beta Rattus norvegicus
7 In a definite concentration ranging from 300 mug/mL to 500 mug/mL, TCDCA showed marked inhibition in the overproduction and mRNA expression of TNF-alpha, IL-1beta and IL-6 in synoviocytes in a concentration-dependent manner, but opposite action on IL-10. Taurochenodeoxycholic Acid interleukin 6 Rattus norvegicus
8 In a definite concentration ranging from 300 mug/mL to 500 mug/mL, TCDCA showed marked inhibition in the overproduction and mRNA expression of TNF-alpha, IL-1beta and IL-6 in synoviocytes in a concentration-dependent manner, but opposite action on IL-10. Taurochenodeoxycholic Acid interleukin 10 Rattus norvegicus
9 In conclusion, treatment with TCDCA confers a good anti-adjuvant arthritis activity in rats, which its reparative effects could be mediated via reduction of the protein and mRNA expression of TNF-alpha, IL-1beta and IL-6, and augment of IL-10 in rats. Taurochenodeoxycholic Acid tumor necrosis factor Rattus norvegicus
10 In conclusion, treatment with TCDCA confers a good anti-adjuvant arthritis activity in rats, which its reparative effects could be mediated via reduction of the protein and mRNA expression of TNF-alpha, IL-1beta and IL-6, and augment of IL-10 in rats. Taurochenodeoxycholic Acid interleukin 1 beta Rattus norvegicus
11 In conclusion, treatment with TCDCA confers a good anti-adjuvant arthritis activity in rats, which its reparative effects could be mediated via reduction of the protein and mRNA expression of TNF-alpha, IL-1beta and IL-6, and augment of IL-10 in rats. Taurochenodeoxycholic Acid interleukin 6 Rattus norvegicus
12 In conclusion, treatment with TCDCA confers a good anti-adjuvant arthritis activity in rats, which its reparative effects could be mediated via reduction of the protein and mRNA expression of TNF-alpha, IL-1beta and IL-6, and augment of IL-10 in rats. Taurochenodeoxycholic Acid interleukin 10 Rattus norvegicus